Drug interactions
Carboplatin + Trastuzumab deruxtecan
Severity: Moderate
Carboplatin and Trastuzumab deruxtecan: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both agents suppress bone marrow function, and trastuzumab deruxtecan causes neutropenia on its own. Together they may increase the frequency and severity of neutropenia, febrile neutropenia and infection.
What this interaction means in plain words
Carboplatin and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Carboplatin belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.
Why it happens
Additive myelosuppression.
What to do
Monitor complete blood counts regularly and hold or reduce doses according to labeled neutropenia guidance. Consider growth factor support where appropriate.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carboplatin and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Carboplatin
Other interactions of Trastuzumab deruxtecan
Frequently asked questions
Can I take Carboplatin with Trastuzumab deruxtecan?
MediHelp rates the interaction as moderate. Carboplatin and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents suppress bone marrow function, and trastuzumab deruxtecan causes neutropenia on its own. Together they may increase the frequency and severity of neutropenia, febrile neutropenia and infection.
How serious is the interaction between Carboplatin and Trastuzumab deruxtecan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts regularly and hold or reduce doses according to labeled neutropenia guidance. Consider growth factor support where appropriate.
What other medicines interact with Carboplatin?
MediHelp also lists interactions of Carboplatin with, for example, Adenovirus types 4 and 7 live, Amikacin, Amphotericin b deoxycholate. The full list is on the Carboplatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
